A Preventative Adenoviral-Based H5N1 Influenza Vaccine
基于腺病毒的预防性 H5N1 流感疫苗
基本信息
- 批准号:7266987
- 负责人:
- 金额:$ 24.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adenovirus VectorAdenovirusesAdultAnimal ModelAntigensAsiansAvian InfluenzaAwarenessBiological ProductsBirdsCambodiaCertificationCessation of lifeChickensChinaClinicalClinical ResearchClinical TrialsControl AnimalCountryCyclic GMPDetectionDevelopmentDiseaseDisease OutbreaksDomestic FowlsDoseEnrollmentEnsureEvaluationExposure toFamilyFerretsFeverFutureGenerationsGoalsHemagglutininHong KongHumanHumoral ImmunitiesImmunityIndonesiaInfectionInflammationInfluenzaInfluenza A Virus, H5N1 SubtypeInfluenza A virusInjection of therapeutic agentJapanLaosLiverManufactured MaterialsMeasuresModelingMusNorth KoreaPerformancePersonal SatisfactionPharmacologyPharmacology and ToxicologyPhasePhase I Clinical TrialsPlacebo ControlPopulationRandomizedReassortant VirusesRecombinantsRegistriesReportingResearchResearch PersonnelResidual stateSafetySalivaSeriesSerotypingSiteSourceSouth KoreaT-LymphocyteTestingThailandThrombocytopeniaToxic effectUnited StatesUniversitiesUrineVaccinatedVaccinationVaccine ResearchVaccinesVietnamViralViral GenomeViral VectorVirusbasecohortdayexposed human populationhealthy volunteerimmunogenicityinfluenza virus vaccineirritationpandemic diseasepre-clinicalprogramsresearch studyresponsetransmission processvaccine evaluationvector
项目摘要
DESCRIPTION (provided by applicant): Wild waterfowl, the natural hosts of all known influenza A viruses, are the source of viruses which cause sporadic outbreaks of highly fatal disease in domestic poultry. Since 1997, highly pathogenic (HP) avian influenza A H5N1 viruses have caused a series of outbreaks in Hong Kong, and most recently in 9 other Asian countries. As human exposure to and infection with H5N1 viruses continues to increase, so too does the likelihood of the generation of an avian-human reassortant virus which may transmit efficiently within the human population which lacks HA-specific immunity to H5N1 viruses. In 1997, HPAl H5N1 in Hong Kong resulted in transmission from poultry to humans, resulting in 18 infected people and six deaths. In 2003- 2005, extensive outbreaks of highly pathogenic avian influenza A (H5N1) occurred in several Asian countries (Cambodia, China, Indonesia, Japan, Laos, South Korea, Thailand and Vietnam, North Korea), resulting in 17 human cases in Thailand and 27 in Vietnam and 3 in Cambodia; there were 51 reported deaths. H5N1 infections in family clusters have raised the possibility of human-to-human transmission of H5N1 virus. We have recently developed an adenoviral-based influenza vaccine encoding the hemagglutinin (HA) antigen of the A/Vietnam/1203/2004 (H5N1) strain isolated during the 2003-2005 lethal human outbreak. Vaccinated mice and chickens had broad virus-specific cellular and humoral immunity and were fully protected from a lethal intranasal H5N1 challenge, whereas all control animals died within few days. Hence, a centralized and integrated clinical vaccine testing will be proposed.
描述(由申请人提供):野生水禽是所有已知甲型流感病毒的天然宿主,是导致家禽零星爆发高度致命疾病的病毒来源。自 1997 年以来,高致病性 (HP) 甲型 H5N1 禽流感病毒在香港以及最近在其他 9 个亚洲国家引发了一系列疫情。随着人类接触和感染 H5N1 病毒的不断增加,产生禽-人重配病毒的可能性也在增加,这种病毒可以在缺乏针对 H5N1 病毒的 HA 特异性免疫力的人群中有效传播。 1997年,香港发生H5N1禽流感病毒,导致18人感染,6人死亡。 2003年至2005年,多个亚洲国家(柬埔寨、中国、印度尼西亚、日本、老挝、韩国、泰国和越南、朝鲜)爆发高致病性甲型H5N1禽流感,造成泰国17人感染病例越南27个,柬埔寨3个;据报道有51人死亡。家庭聚集性H5N1感染增加了H5N1病毒人传人的可能性。我们最近开发了一种基于腺病毒的流感疫苗,编码 2003-2005 年致命人类疫情期间分离出的 A/Vietnam/1203/2004 (H5N1) 毒株的血凝素 (HA) 抗原。接种疫苗的小鼠和鸡具有广泛的病毒特异性细胞和体液免疫力,并且完全免受致命的鼻内 H5N1 攻击,而所有对照动物都在几天内死亡。因此,将提出集中、综合的临床疫苗测试。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Assessment of route of administration and dose escalation for an adenovirus-based influenza A Virus (H5N1) vaccine in chickens.
评估基于腺病毒的甲型流感病毒 (H5N1) 鸡疫苗的给药途径和剂量递增。
- DOI:10.1128/cvi.00180-10
- 发表时间:2010
- 期刊:
- 影响因子:0
- 作者:Steitz,Julia;Wagner,RobertA;Bristol,Tyler;Gao,Wentao;Donis,RubenO;Gambotto,Andrea
- 通讯作者:Gambotto,Andrea
A candidate H1N1 pandemic influenza vaccine elicits protective immunity in mice.
- DOI:10.1371/journal.pone.0010492
- 发表时间:2010-05-05
- 期刊:
- 影响因子:3.7
- 作者:Steitz J;Barlow PG;Hossain J;Kim E;Okada K;Kenniston T;Rea S;Donis RO;Gambotto A
- 通讯作者:Gambotto A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREA GAMBOTTO其他文献
ANDREA GAMBOTTO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREA GAMBOTTO', 18)}}的其他基金
Pre-clinical evaluation of an adenoviral-based MERS-CoV vaccine
基于腺病毒的 MERS-CoV 疫苗的临床前评估
- 批准号:
8839373 - 财政年份:2015
- 资助金额:
$ 24.36万 - 项目类别:
Pre-clinical evaluation of an adenoviral-based MERS-CoV vaccine
基于腺病毒的 MERS-CoV 疫苗的临床前评估
- 批准号:
9108846 - 财政年份:2015
- 资助金额:
$ 24.36万 - 项目类别:
Adenoviral-based vaccine platform to overcome neutralizing immunity
基于腺病毒的疫苗平台克服中和免疫
- 批准号:
7777925 - 财政年份:2010
- 资助金额:
$ 24.36万 - 项目类别:
Adenoviral-based vaccine platform to overcome neutralizing immunity
基于腺病毒的疫苗平台克服中和免疫
- 批准号:
8070415 - 财政年份:2010
- 资助金额:
$ 24.36万 - 项目类别:
A Preventative Adenoviral-Based H5N1 Influenza Vaccine
基于腺病毒的预防性 H5N1 流感疫苗
- 批准号:
7077267 - 财政年份:2006
- 资助金额:
$ 24.36万 - 项目类别:
相似国自然基金
基于sIgA的V(D)J结构多样性探索腺病毒载体鼻喷新冠奥密克戎疫苗诱导的呼吸道粘膜免疫原性特征
- 批准号:82302607
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
肝胆肿瘤治疗性溶瘤腺病毒疫苗的研制及其临床前应用性探索
- 批准号:82303776
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
CD46和DSG2双受体在人B组腺病毒感染与致病中的协同作用和机制研究
- 批准号:32370155
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
PD-1/PD-L1信号促CD21-B细胞BCR髓外二次编辑降低自身反应性在儿童腺病毒肺炎中的作用机制研究
- 批准号:82370015
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
禽腺病毒血清11型反向遗传平台的建立与毒株间致病性差异机制探究
- 批准号:32372997
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
A novel therapeutic approach for Alzheimer Disease (AD)
阿尔茨海默病(AD)的新治疗方法
- 批准号:
10740016 - 财政年份:2023
- 资助金额:
$ 24.36万 - 项目类别:
The protective role of fibroblast growth factor signaling in hypoxia-induced pulmonary hypertension
成纤维细胞生长因子信号传导在缺氧诱导的肺动脉高压中的保护作用
- 批准号:
10506740 - 财政年份:2022
- 资助金额:
$ 24.36万 - 项目类别:
The protective role of fibroblast growth factor signaling in hypoxia-induced pulmonary hypertension
成纤维细胞生长因子信号传导在缺氧诱导的肺动脉高压中的保护作用
- 批准号:
10707357 - 财政年份:2022
- 资助金额:
$ 24.36万 - 项目类别:
cGAS-STING Pathway Targeting Replicative Adenoviruses with CD46 Tropism and AFP Promoter Conditional Replication Restriction for the Treatment of Hepatocellular Carcinoma
cGAS-STING 通路靶向具有 CD46 趋向性和 AFP 启动子的复制腺病毒条件性复制限制用于治疗肝细胞癌
- 批准号:
10436626 - 财政年份:2021
- 资助金额:
$ 24.36万 - 项目类别:
Role of epithelial cell intracellular trafficking in the innate immune response to adenovirus infection
上皮细胞胞内运输在腺病毒感染先天免疫反应中的作用
- 批准号:
10209611 - 财政年份:2021
- 资助金额:
$ 24.36万 - 项目类别: